S2WB4003: Unpublished study of zolmitriptan, naratriptan and placebo in patients with migraine

Authors
Category Primary study
UnpublishedInformation reported in a systematic review
Year 2002
This reference is based in information provided by a meta-analysis (Ferrari MD, et al. Cephalalgia. 2002 Oct;22(8):633-58. doi: 10.1046/j.1468-2982.2002.00404.x) reporting unpublished data obtained by the authors. This record has been prepared by collaborators of Epistemonikos. The study S2WB4003 was a parallel randomized trial that evaluated patients with migraine, with 75 patients receiving zolmitriptan 2.5 mg, 79 receiving naratriptan 2.5 mg, and 27 receiving a placebo.
Epistemonikos ID: 7cdc9ccebbfb8135a0f7178e6278a898c748e776
First added on: Nov 07, 2024